IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 24 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,731,802 | – | 4,698 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 27,432 | $29,048 | 1.97% |
| SHENKMAN CAPITAL MANAGEMENT INC | 16,386,000 | $17,545,909 | 1.09% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,416,000 | $5,828,097 | 0.88% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,000,000 | $12,996,787 | 0.31% |
| CSS LLC/IL | 5,000,000 | $5,411,355 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 22,491,000 | $24,353,056 | 0.25% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 22,700,000 | $24,473,438 | 0.18% |
| Calamos Advisors LLC | 7,500,000 | $8,121,900 | 0.04% |
| Citadel Advisors | 76,517,000 | $82,494,920 | 0.02% |
| AVIVA PLC | 3,000,000 | $3,204,300 | 0.02% |